All Stories

  1. Psychometric properties of the Insomnia Severity Index in Ethiopian adults with substance use problems
  2. The association of BDNF gene polymorphism with cognitive impairment in insomnia patients
  3. Sleep, Oh Sleep, Where Art Thou?
  4. Why We Sleep: The New Science of Sleep and Dreams by Matthew Walker, Ph.D.
  5. Are Type 2 Diabetes Mellitus and Depression Part of a Common Clock Genes Network?
  6. Nonadherence to antihypertensive medications in adults with high risk for obstructive sleep apnea
  7. The SAVE Trial: Has the Importance of CPAP for Preventing Cardiovascular Events been Discounted?
  8. Factor scoring models of the Pittsburgh Sleep Quality Index: a comparative confirmatory factor analysis
  9. The Effects of Benzodiazepine and Nonbenzodiazepine Agents, Ramelteon, Low-dose Doxepin, Suvorexant, and Selective Serotonin 5-HT2A Receptor Antagonists and Inverse Agonists on Sleep and Wakefulness
  10. Gender differences in patients with obesity hypoventilation syndrome
  11. Spontaneous K-Complex Density in Slow-Wave Sleep
  12. Association of Sleep Duration with Stroke in Diabetic Patients: Analysis of the National Health Interview Survey
  13. The effect of Ramadan intermittent fasting on lipid peroxidation in healthy young men while controlling for diet and sleep: A pilot study
  14. Sleep in space as a new medical frontier: the challenge of preserving normal sleep in the abnormal environment of space missions
  15. Restless legs syndrome and pregnancy: prevalence, possible pathophysiological mechanisms and treatment
  16. Evidence for daily and weekly rhythmicity but not lunar or seasonal rhythmicity of physical activity in a large cohort of individuals from five different countries
  17. Association between sleep quality and inflammatory complement components in collegiate males
  18. Linking emotional distress to unhealthy sleep duration: analysis of the 2009 National Health Interview Survey
  19. Some implications of melatonin use in chronopharmacology of insomnia
  20. Sleep insufficiency and the natural environment: Results from the US Behavioral Risk Factor Surveillance System survey
  21. Comorbid depression in obstructive sleep apnea: an under-recognized association
  22. Daily activity patterns of 2316 men and women from five countries differing in socioeconomic development
  23. Project Stakeholder Management in the Clinical Research Environment: How to Do it Right
  24. Validity of the Pittsburgh Sleep Quality Index in Indian University Students
  25. Associations between sleep disturbances and diabetes mellitus among blacks with metabolic syndrome: Results from the Metabolic Syndrome Outcome Study (MetSO)
  26. Melatonin and brain inflammaging
  27. Orexin and Sleep
  28. Role of Orexin on Sleep: Interactions with Other Neurotransmitter Systems
  29. Sleep as a Mediator in the Pathway Linking Environmental Factors to Hypertension: A Review of the Literature
  30. Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
  31. When insomnia is not just insomnia: The deeper correlates of disturbed sleep with reference to DSM-5
  32. Tasimelteon
  33. Sodium Oxybate (Xyrem®): A New and Effective Treatment for Narcolepsy with Cataplexy
  34. Should we listen to our clock to prevent type 2 diabetes mellitus?
  35. Association between visual impairment and sleep duration: analysis of the 2009 National Health Interview Survey (NHIS)
  36. Diurnal Intermittent Fasting during Ramadan: The Effects on Leptin and Ghrelin Levels
  37. Cognitive behavioral treatment for narcolepsy: can it complement pharmacotherapy?
  38. Prevalence of sleep-related accidents among drivers in Saudi Arabia
  39. Effects of Melatonin and Epiphyseal Proteins on Fluoride-Induced Adverse Changes in Antioxidant Status of Heart, Liver, and Kidney of Rats
  40. Clock genes in type 2 diabetes
  41. Intermittent fasting during Ramadan: does it affect sleep?
  42. Sleep and circadian rhythm dysregulation in schizophrenia
  43. Objective assessment of drowsiness and reaction time during intermittent Ramadan fasting in young men: a case-crossover study
  44. Narcolepsy or Sleep Apnea?: Not Everything is What it Appears to be!
  45. Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes
  46. Sleep architecture of consolidated and split sleep due to the dawn (Fajr) prayer among Muslims and its impact on daytime sleepiness
  47. Evaluation of blood antioxidant defense and apoptosis in peripheral lymphocytes on exogenous administration of pineal proteins and melatonin in rats
  48. Melatonergic Drugs in Clinical Practice
  49. Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection
  50. Melatonin agonists in primary insomnia and depression-associated insomnia: Are they superior to sedative-hypnotics?
  51. Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
  52. Melatonin—A pleiotropic, orchestrating regulator molecule
  53. Cerebral Epiphyseal Proteins and Melatonin Modulate the Hepatic and Renal Antioxidant Defense of Rats
  54. Melatonin in Mitochondrial Dysfunction and Related Disorders
  55. Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
  56. Rapid Eye Movement Sleep
  57. Melatonin in septic shock: Some recent concepts
  58. Measurement of melatonin in body fluids: Standards, protocols and procedures
  59. Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs
  60. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis
  61. Potential use of melatonergic drugs in analgesia: Mechanisms of action
  62. Interfacing Sleep and Aging
  63. GABA and Sleep
  64. Malaria: therapeutic implications of melatonin
  65. Great challenges to sleep medicine: problems and paradigms
  66. Narcolepsy
  67. Melatonin and human reproduction: Shedding light on the darkness hormone
  68. Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine
  69. Ramelteon: a review of its therapeutic potential in sleep disorders
  70. Melatonin and its relevance to jet lag
  71. Pathophysiology of depression: Role of sleep and the melatonergic system
  72. Melatonin and human reproduction: Shedding light on the darkness hormone
  73. Sleep and Mental Illness
  74. The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives
  75. Melatonin and Melatonergic Drugs on Sleep: Possible Mechanisms of Action
  76. Drugs, Driving and Traffic Safety
  77. Principles and Practice of Geriatric Sleep Medicine
  78. Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms
  79. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders
  80. Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
  81. ChemInform Abstract: Melatonergic Drugs in Clinical Practice
  82. 24-Hour rhythms in oxidative stress during hepatocarcinogenesis in rats: effect of melatonin or α-ketoglutarate
  83. Therapeutic potential of melatonin agonists
  84. Immunomodulation by Melatonin: Its Significance for Seasonally Occurring Diseases
  85. Melatonin and the Immune System in Aging
  86. Jet lag: Therapeutic use of melatonin and possible application of melatonin analogs
  87. Serotonin and Sleep: Molecular, Functional and Clinical Aspects
  88. Neurochemistry of Sleep and Wakefulness
  89. Sleep and Quality of Life in Clinical Medicine
  90. Effects of Sleep Medications on Cognition, Psychomotor Skills, Memory and Driving Performance in the Elderly
  91. Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats
  92. Prevention by melatonin of hepatocarcinogenesis in rats injected with N‐nitrosodiethylamine
  93. Melatonin in the eye: Implications for glaucoma
  94. Melatonin, environmental light, and breast cancer
  95. Drug Insight: the use of melatonergic agonists for the treatment of insomnia—focus on ramelteon
  96. Role of the Melatonin System in the Control of Sleep
  97. Dim light melatonin onset (DLMO): A tool for the analysis of circadian phase in human sleep and chronobiological disorders
  98. Erratum
  99. Neuroimmunology of Sleep
  100. Role of melatonin in the eye and ocular dysfunctions
  101. Could agomelatine be the ideal antidepressant?
  102. Melatonin.
  103. Sleep disorders, sleepiness and traffic safety: a public health menace
  104. Erratum
  105. The role of melatonin in immuno-enhancement: potential application in cancer
  106. Melatonin
  107. Sleep and Circadian Neuroendocrine Function in Seasonal Affective Disorder
  108. Clinical Pharmacology of Sleep
  109. Melatonin in Circadian Rhythm Sleep Disorders
  110. Melatonin in mood disorders
  111. Sleep and Sleep Disorders
  112. Sleep and Epilepsy
  113. Time-Dependent Psychotropic Drug Effects
  114. Melatonin and sleep in aging population
  115. Role of melatonin in neurodegenerative diseases
  116. Neuroendocrine Correlates of Sleep/Wakefulness
  117. Does melatonin play a disease-promoting role in rheumatoid arthritis?
  118. Circadian organization of the immune response: A role for melatonin
  119. REM sleep reduction, mood regulation and remission in untreated depression
  120. Senescence, sleep, and circadian rhythms
  121. Sleep in seasonal affective disorder
  122. Melatonin and mental illness
  123. Circadian control by serotonin and melatonin receptors: Clinical relevance
  124. Circadian Organization of the Immune Response
  125. Preface
  126. Organization of the first edition
  127. Preface
  128. Dim light melatonin onset in psychiatric disorders
  129. Aging and circadian rhythms: general trends
  130. Melatonin and its receptors: biological function in circadian sleep–wake regulation
  131. Melatonin and Quality of Life